A new phenothiazine derivate is active against Clostridioides difficile and shows low cytotoxicity.
The rapid evolution of antibiotic resistance in Clostridioides difficile and the consequent effects on prevention and treatment of C. difficile infections (CDIs) are matters of concern for public health. Thioridazine, a compound belonging to the phenothiazine group, has previous shown antimicrobial...
Guardado en:
Autores principales: | Troels Ronco, Francisca Maria Aragao, Lasse Saaby, Jørn B Christensen, Anders Permin, Andrew R Williams, Stig M Thamsborg, Rikke H Olsen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ea30fd443644510893431c84e425e63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epidemiology of Clostridioides difficile in South Africa.
por: Pieter de Jager, et al.
Publicado: (2021) -
Faecal transplantation and Clostridioides difficile infection
por: Knežević Darija A., et al.
Publicado: (2021) -
Plasmid-mediated metronidazole resistance in Clostridioides difficile
por: Ilse M. Boekhoud, et al.
Publicado: (2020) -
Identification of linear epitopes on the flagellar proteins of Clostridioides difficile
por: A. Razim, et al.
Publicado: (2021) -
Effective inhibition of Clostridioides difficile by the novel peptide CM-A.
por: Sirirak Arthithanyaroj, et al.
Publicado: (2021)